Abbott's XIENCE PRIME stent wins FDA approval

11/2/2011 | Reuters

The FDA has granted Abbott Laboratories approval for its XIENCE PRIME everolimus-eluting stent for use in treating patients with coronary artery disease. The device has an improved design that allows more flexibility and accuracy in stent delivery and placement.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC